2012-10-10 21:31:55 - New Pharmaceuticals market report from Global Markets Direct: "Bionor Pharma ASA - Product Pipeline Review - 2012"

Global Market Direct's pharmaceuticals report, "Bionor Pharma ASA - Product Pipeline Review - 2012" provides data on the Bionor Pharma ASA's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Bionor Pharma ASA's corporate website, SEC filings, investor presentations and featured press releases, both from Bionor Pharma ASA and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Bionor Pharma ASA - Brief Bionor Pharma ASA overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Bionor Pharma ASA human

therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Bionor Pharma ASA with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Bionor Pharma ASA's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/468513_bionor_pharma_asa_product_pipeline_re ..


Reasons to buy

* Evaluate Bionor Pharma ASA's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Bionor Pharma ASA in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Bionor Pharma ASA's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Bionor Pharma ASA.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Bionor Pharma ASA and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Bionor Pharma ASA Snapshot
Bionor Pharma ASA Overview
Key Information
Key Facts
Bionor Pharma ASA - Research and Development Overview
Key Therapeutic Areas
Bionor Pharma ASA - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Bionor Pharma ASA - Pipeline Products Glance
Bionor Pharma ASA Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Bionor Pharma ASA - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Bionor Pharma ASA - Drug Profiles
HCV Vaccine
Product Description
Mechanism of Action
R&D Progress
Influenza vaccine
Product Description
Mechanism of Action
R&D Progress
Vacc 4x + Revlimid
Product Description
Mechanism of Action
R&D Progress
Vacc-4x
Product Description
Mechanism of Action
R&D Progress
Vacc-C5
Product Description
Mechanism of Action
R&D Progress
Vacc-HIV
Product Description
Mechanism of Action
R&D Progress
Bionor Pharma ASA - Pipeline Products by Route of Administration
Bionor Pharma ASA - Recent Pipeline Updates
Bionor Pharma ASA - Company Statement
Bionor Pharma ASA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Bionor Pharma ASA, Recent Developments
Bionor Pharma ASA- Press Release
Aug 13, 2012: Bionor Pharma Receives Approval To Begin Clinical Study Combining Vacc-4x With Celgene's Revlimid In Germany
Jul 20, 2012: Bionor Pharma Presents Phase II Study Data Of Vacc-4x At International AIDS Society Symposium
Jul 06, 2012: GLOBVAC Awards Bionor Pharma $1.7m To Advance Research Towards HIV Cure Using Vaccine Vacc-4x
Jun 07, 2012: Bionor Pharma Initiates Patent Process For Protection Of Vacc-HIV
Jun 07, 2012: Bionor Pharma Submits International Patent Application For Cytomegalovirus Vaccine
Jun 07, 2012: Bionor Pharma Submits International Patent Application For Hepatitis C Vaccine
Jun 07, 2012: Bionor Pharma Submits International Patent Application For Human Papillomavirus Vaccine
Jun 07, 2012: Bionor Pharma Submits International Patent Application For Influenza Vaccine
May 29, 2012: Bionor Pharma To Begin First Human Study Of HIV Vaccine, Vacc-C5
May 10, 2012: Bionor Pharma, Eurocine Vaccines And Oslo University Announce Successful Results From Immunization Study Of Vacc-4x And Endocine
Apr 10, 2012: Bionor Pharma Expects Results From Nasal Administration Study Of Vacc-4x And Endocine In May 2012
Feb 15, 2012: Bionor Pharma Reports Positive Phase II Results For HIV Vaccine, Vacc-4x
Jan 23, 2012: Bionor Completes Submission Of Final Documents For International Patent Application Of Vacc-4x
Jan 23, 2012: Bionor Completes Submission Of Final Documents For International Patent Application Of Vacc-C5
Jan 04, 2012: Bionor Pharma, Eurocine Vaccines And Oslo University Announce Completion Of Enrollment For HIV Nasal Immunization Study
Financial Deals Landscape
Bionor Pharma ASA, Deals Summary
Bionor Pharma ASA, Pharmaceuticals & Healthcare, Deal Details
Partnerships

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468513&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.